Silence Therapeutics Statistics
Total Valuation
SLN has a market cap or net worth of $324.31 million. The enterprise value is $151.61 million.
Important Dates
The last earnings date was Thursday, November 14, 2024, before market open.
| Earnings Date | Nov 14, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
SLN has 46.80 million shares outstanding. The number of shares has increased by 21.50% in one year.
| Current Share Class | n/a |
| Shares Outstanding | 46.80M |
| Shares Change (YoY) | +21.50% |
| Shares Change (QoQ) | +0.87% |
| Owned by Insiders (%) | 26.60% |
| Owned by Institutions (%) | 44.13% |
| Float | 22.72M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 14.06 |
| Forward PS | n/a |
| PB Ratio | 2.58 |
| P/TBV Ratio | 2.79 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 6.96 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 9.31, with a Debt / Equity ratio of 0.00.
| Current Ratio | 9.31 |
| Quick Ratio | 8.61 |
| Debt / Equity | 0.00 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -6.81 |
Financial Efficiency
Return on equity (ROE) is -102.80% and return on invested capital (ROIC) is -63.40%.
| Return on Equity (ROE) | -102.80% |
| Return on Assets (ROA) | -27.27% |
| Return on Capital (ROIC) | -63.40% |
| Revenue Per Employee | $199,754 |
| Profits Per Employee | -$723,788 |
| Employee Count | 109 |
| Asset Turnover | 0.12 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | -9.47M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -23.85% in the last 52 weeks. The beta is 1.29, so SLN's price volatility has been higher than the market average.
| Beta (5Y) | 1.29 |
| 52-Week Price Change | -23.85% |
| 50-Day Moving Average | 17.35 |
| 200-Day Moving Average | 20.05 |
| Relative Strength Index (RSI) | 7.80 |
| Average Volume (20 Days) | 544,045 |
Short Selling Information
| Short Interest | 353,316 |
| Short Previous Month | 334,630 |
| Short % of Shares Out | 0.75% |
| Short % of Float | 1.56% |
| Short Ratio (days to cover) | 2.36 |
Income Statement
In the last 12 months, SLN had revenue of $21.77 million and -$78.89 million in losses. Loss per share was -$1.79.
| Revenue | 21.77M |
| Gross Profit | 9.75M |
| Operating Income | -78.16M |
| Pretax Income | -52.45M |
| Net Income | -78.89M |
| EBITDA | -77.74M |
| EBIT | -78.16M |
| Loss Per Share | -$1.79 |
Full Income StatementBalance Sheet
The company has $172.89 million in cash and $186,302 in debt, giving a net cash position of $172.70 million or $3.69 per share.
| Cash & Cash Equivalents | 172.89M |
| Total Debt | 186,302 |
| Net Cash | 172.70M |
| Net Cash Per Share | $3.69 |
| Equity (Book Value) | 126.68M |
| Book Value Per Share | 2.69 |
| Working Capital | 188.45M |
Full Balance SheetCash Flow
| Operating Cash Flow | n/a |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Full Cash Flow StatementMargins
| Gross Margin | 44.78% |
| Operating Margin | -358.97% |
| Pretax Margin | -405.85% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | -148.14% |